article thumbnail

Direct to Patient Healthcare

Healthcare Success

Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.

article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled.

Pharma 105
article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. “I think the healthcare market is probably very similar.

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

article thumbnail

Integrated evidence generation 2.0: A strategy for every stakeholder

pharmaphorum

The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation.

article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

pharmaphorum

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. However, what is clearer still is that vulnerable groups need support and healthcare systems need to adapt to become stronger and more resistant.

article thumbnail

FINN Partners Further Expands into Asia with Addition of SPAG

PM360

SPAG, which serves global biopharma companies, health trade associations, and health provider systems, is also one of the most awarded agencies in the region having been named Global New PR Agency in 2015, Asia-Pacific Healthcare Agency of Year (2017 & 2019) at Sabre awards, and Large Agency of the Year in 2021 & 2022 by E4M (IPRCCA).